Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
Sponsor: University of Colorado, Denver
Listed as NCT03112226, this NA trial focuses on Cognitive Impairment and Endothelial Dysfunction and remains completed. Sponsored by University of Colorado, Denver, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Nov 2019 — Aug 2020 [monthly]
Recruiting NA
-
Aug 2018 — Nov 2019 [monthly]
Recruiting NA
-
Jul 2018 — Aug 2018 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .